FDA Inspection 1251717 — Blood Bank Of Delmarva, A Division Of New York Blood Center, Inc.

Blood Bank Of Delmarva, A Division Of New York Blood Center, Inc. — FEI 2577603

The FDA completed an inspection of Blood Bank Of Delmarva, A Division Of New York Blood Center, Inc. on Sep 24, 2024 in Newark, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Sep 24, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Newark, DE (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.